VIATRIS INC. Long-Term Debt
VIATRIS INC. (VTRS) had Long-Term Debt of $11.61 billion as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermDebtNoncurrent · last filed 2026-08-06
- 2026-06-30: Long-term Debt, Excluding Current Maturities $11.61B.
- 2026-03-31: Long-term Debt, Excluding Current Maturities $12.41B.
- 2025-12-31: Long-term Debt, Excluding Current Maturities $12.48B.
- 2025-09-30: Long-term Debt, Excluding Current Maturities $12.49B.
| Period end | Long-term Debt, Excluding Current Maturities | Long-term Debt, Excluding Current Maturities as first filed |
|---|---|---|
| 2026-06-30 | $11.61B 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $12.41B 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $12.48B 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $12.49B 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $12.79B 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $14.18B 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $14.04B 10-K · filed 2026-02-26 | |
| 2024-09-30 | $14.30B 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $14.73B 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $16.07B 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $16.19B 10-K · filed 2025-02-27 | |
| 2023-09-30 | $17.08B 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $17.25B 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $18.07B 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $18.02B 10-K · filed 2024-02-28 | |
| 2022-09-30 | $18.72B 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $19.21B 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $18.76B 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $19.72B 10-K · filed 2023-02-27 | |
| 2021-09-30 | $19.85B 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $20.92B 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $22.10B 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $22.43B 10-K · filed 2022-02-28 | |
| 2020-09-27 | $11.54B 10-Q · filed 2020-11-10 | |
| 2020-06-28 | $11.39B 10-Q · filed 2020-08-12 | |
| 2019-12-31 | $11.21B 10-K · filed 2021-03-01 | $0.00 10-Q · filed 2020-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |